NCT03928015View on ClinicalTrials.gov

Evaluation of Dronabinol For Acute Pain Following Traumatic Injury

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 1, 2019

Primary Completion Date

June 29, 2021

Study Completion Date

June 29, 2021

Conditions
Traumatic InjuryPain, Acute
Interventions
DRUG

Adjunctive dronabinol

5mg BID and adjusting within the range of 2.5mg - 10mg BID, minimum of 48 hours, as an adjunct to systemic analgesics

DRUG

Systemic analgesics

multimodal analgesia including opioid and non-opioid analgesics

Trial Locations (1)

80228

St. Anthony Hospital, Lakewood

Sponsors
All Listed Sponsors
lead

CommonSpirit Health

OTHER